ArticleJournal of inflammation research2025
Early Immune-Inflammatory Profiling and Prognostic Biomarkers in Patients with Acute Diquat Poisoning: A Multicenter Study with Exploratory Bioinformatics Analysis.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pre-treatment with baicalein alleviates the diquat-induced microglial pyroptosis through gut microbiota-derived indole-3-propionic acid and DDX3X/G3BP1 pathway.Cell biology and toxicology · 2026Article
- Combined predictive value of dose, MODS, and NLR for lethal risk of diquat poisoning: a retrospective cohort study.Frontiers in toxicology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: With the increasing incidence of acute diquat (DQ) poisoning, this study aims to analyze immune biomarkers in patients and explore their impact on outcomes. Methods: A retrospective multicenter cohort study included 145 patients with acute DQ poisoning from six hospitals in Zhejiang Province, China. Immune-inflammatory parameters were compared between DQ patients and healthy controls. Patients were then grouped according to their 28-day survival status for prognostic analysis. Clinical, laboratory, and immune parameters were collected. Least absolute shrinkage and selection operator (LASSO) regression, multivariate logistic regression, and receiver operating characteristic analysis were used to identify predictors of mortality. Bioinformatics analysis was performed to explore potential molecular targets and pathways. Results: Of 145 patients, 72 died within 28 days. Non-survivors showed higher procalcitonin (PCT), lactate, and organ injury markers, as well as elevated interleukin-6 and interleukin-10, compared with survivors. Compared with healthy controls, patients with DQ poisoning exhibited increased white blood cells (WBC), neutrophils, monocytes, and cytokines, alongside reduced lymphocytes and T-cell subsets (all Conclusion: Acute DQ poisoning causes pronounced immune-inflammatory disturbances that are more severe in non-survivors. PCT is the strongest independent predictor of 28-day mortality, while exploratory bioinformatics highlights immune pathways with potential prognostic and therapeutic relevance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.